Debra Perry advises regulated biological product, pharmaceutical, and medical device companies on legal and compliance issues during the development, marketing and distribution phases of their products. She provides strategic planning and risk management guidance regarding FDA submissions, conduct of clinical trials, enforcement issues, and post-approval promotional, marketing and labeling issues.
Debra also defends pharmaceutical and other manufacturers in mass tort product liability litigation at the trial and appellate levels in state and federal courts. She has significant experience representing multinational companies in prescription and OTC medication litigation, including atypical anti-psychotics, anti depressants, hormone products, narcotic analgesics, and diabetes drugs. She also defends multinational corporations against industrial product liability claims, and helps companies select, train, and manage defense counsel nationwide and abroad.
Debra develops and implements strategies to confront the complex issues that arise in these types of litigation, including multi-district issues, defense of medical monitoring claims, federal preemption, product identification and market share liability, punitive damages, exposure, epidemiological analysis of causation, and Daubert (and its state law equivalents) hearings on the admissibility of medical and scientific expert testimony, and the application of statutes of limitations.
Debra also handles complex guardianship and estate matters in the Superior Court of New Jersey, Chancery Division, Probate Part. She lectures and writes extensively about compliance and risk management and was recognized as a New Jersey Super Lawyer for 2005–2006, 2008-2010 and 2014.